Targeting breast cancer stem cells with HER2-specific antibodies and natural killer cells

Breast cancer is the most common cancer among women worldwide. Every year, nearly 1.4 million new cases of breast cancer are diagnosed, and about 450.000 women die of the disease. Approximately 15-25% of breast cancer cases exhibit increased quantities of the trans-membrane receptor tyrosine kinase...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Diessner, Joachim, Bruttel, Valentin, Becker, Kathrin, Pawlik, Miriam, Stein, Roland, Häusler, Sebastian, Dietl, Johannes, Wischhusen, Jörg, Hönig, Arnd
Formato: Artigo
Lenguaje:Inglês
Publicado: e-Century Publishing Corporation 2013
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3623839/
https://ncbi.nlm.nih.gov/pubmed/23593542
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares